Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the data from the pivotal Phase 3 SOLSTICE clinical trial of LIVTENCITY™ (maribavir, TAK-620) in post-transplant refractory† CMV infections with or without resistance‡ (R/R) were published in the journal of Clinical Infectious Diseases (CID).

Related Keywords

Osaka , Japan , United States , America , Clin Virol , Takeda Pharmaceuticals United States Inc , International Report On Organ Donation , Takeda Pharmaceutical Company Limited , World Health Organization , Takeda Pharmaceutical Company , Exchange Commission , Springer International Publishing , Infectious Diseases Society Of America , The Global Phase , Now Published In Clinical Infectious Diseases , Show For The Primary Endpoint , Key Secondary Endpoint , Lower Limit Of Quantification , Symptom Control , Maintenance Through Week , Pharmaceutical Company Limited , Clinical Infectious Diseases , Infectious Diseases Society , Reduced Antiviral Activity When Co Administered , Failure During Treatment , Adverse Reactions , Virologic Response Due , Full Prescribing , Rare Genetics , Plasma Derived Therapies , Annual Report , Refractory Cytomegalovirus Infections With , Without Resistance Post Transplant , Results From , Clin Infect , Internal Communication , Pharmaceuticals United States Inc All , International Report , Organ Donation , Current Scientific Evidence , Hematopoietic Cell , Leed G , Cytomegalovirus Infections , Hematopoietic Stem Cell Transplantation , Current Status , Intj Mol , Solid Organ Transplant , European Blood , Marrow Transplantation Textbook , Refractory Cytomegalovirus Infection , Transplant Recipients , Hematopoietic Stem Cell Transplant , Biol Blood Marrow , Media Contact , Takeda , Harmaceutical , Ivotal Phase 3 Solstice Clinical Trial , Ivtencity , Maribavir , Ak 620 , Obi Umeh , Fernanda Silveira , Anciclovir , Alganciclovir , Idofovir , Oscarnet , Cytomegalovirus , Dmv , Eta Herpesvirus , Olstice , Virologic Failure , Rug Concentrations , Ncology , Care Genetics , Hematology , Neuroscience , Astroenterology ,